PB
Pierre Belichard, PhD, MBA
Chief Executive Officer, Co-founder
EnteromeEnterome Pipeline
| Drug | Indication | Phase |
|---|
| EO2463 | Indolent Non-Hodgkin Lymphomas (Follicular Lymphoma) | Phase 2 |
| EO2401 | Glioblastoma and Adrenal Tumors | Phase 2 |
| EO4010 | Third-line Colorectal Cancer | Phase 2 |